Hypertension: diagnosis coverage among adults aged 30-79 with in WPR
WPR: Hypertension: diagnosis coverage among adults aged 30-79 with was 51.2% in 2019. ▲ Rising
Hypertension: diagnosis coverage among adults aged 30-79 with in WPR, 1990–2019
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hypertension: diagnosis coverage among adults aged 30-79 with in WPR is 51.2%, measured in 2019. That is the highest value across all 30 years on record.
The figure is up 0.6% on the previous year and up 11.8% over ten years.
Over the whole period, hypertension: diagnosis coverage among adults aged 30-79 with in WPR peaked at 51.2% in 2019 and was at its lowest, 30.2%, in 1990.
The long-run direction has been consistently rising across the 30 years of available data.
Hypertension: diagnosis coverage among adults aged 30-79 with in WPR, year by year
| Year | Value | Change |
|---|---|---|
| 1990 | 30.2% | — |
| 1991 | 31.0% | +2.4% |
| 1992 | 31.7% | +2.4% |
| 1993 | 32.5% | +2.3% |
| 1994 | 33.2% | +2.2% |
| 1995 | 33.9% | +2.2% |
| 1996 | 34.6% | +2.1% |
| 1997 | 35.3% | +2.1% |
| 1998 | 36.0% | +2.0% |
| 1999 | 36.8% | +2.0% |
| 2000 | 37.5% | +2.0% |
| 2001 | 38.3% | +2.1% |
| 2002 | 39.1% | +2.1% |
| 2003 | 40.0% | +2.2% |
| 2004 | 40.9% | +2.3% |
| 2005 | 41.9% | +2.4% |
| 2006 | 42.9% | +2.4% |
| 2007 | 43.9% | +2.4% |
| 2008 | 44.9% | +2.3% |
| 2009 | 45.8% | +2.2% |
| 2010 | 46.8% | +2.0% |
| 2011 | 47.6% | +1.8% |
| 2012 | 48.3% | +1.5% |
| 2013 | 48.9% | +1.3% |
| 2014 | 49.4% | +1.1% |
| 2015 | 49.9% | +0.9% |
| 2016 | 50.3% | +0.8% |
| 2017 | 50.6% | +0.7% |
| 2018 | 50.9% | +0.6% |
| 2019 | 51.2% | +0.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 33.5% | 30.2% | 36.8% | 10 |
| 2000s | 41.5% | 37.5% | 45.8% | 10 |
| 2010s | 49.4% | 46.8% | 51.2% | 10 |
Countries ranked near WPR
- 5 Costa Rica 77.0% compare
- 6 Croatia 74.5% compare
- 7 Russian Federation 74.3% compare
- 8 El Salvador 73.2% compare
- 9 Switzerland 73.1% compare
- 9 Czechia 73.1% compare
- 11 Venezuela, Bolivarian Republic of 72.4% compare
- 11 Slovakia 72.4% compare
More health data for WPR
- Mortality rate among children ages 5 to 9 years 1.24 (2024)
- Population with primary reliance on polluting fuels and technologies 176.35 (2023)
- Proportion of population with primary reliance on fuels and 23.1% (2023)
- Population with primary reliance on fuels and technologies for 152.67 (2023)
- Prevalence of diabetes, crude 12.94 (2022)
- Measles-containing-vaccine first-dose (MCV1) immunization coverage 89.0% (2025)
- Diphtheria tetanus toxoid and pertussis first-dose (DTP1) 91.0% (2025)
- New HIV infections 0.1 (2025)
- BCG immunization coverage among 1-year-olds (%) 92.0% (2025)
- Mean HDL cholesterol, crude 1.3 (2018)
Frequently asked questions
- What is hypertension: diagnosis coverage among adults aged 30-79 with in WPR?
- Hypertension: diagnosis coverage among adults aged 30-79 with in WPR was 51.2% in 2019, according to World Health Organization, Global Health Observatory.
- What is the highest hypertension: diagnosis coverage among adults aged 30-79 with recorded in WPR?
- The highest recorded value was 51.2% in 2019.
- What is the lowest hypertension: diagnosis coverage among adults aged 30-79 with recorded in WPR?
- The lowest recorded value was 30.2% in 1990.
- How does WPR rank for hypertension: diagnosis coverage among adults aged 30-79 with?
- WPR ranks 8th out of 17 groups with data for 2019.
- Is hypertension: diagnosis coverage among adults aged 30-79 with rising or falling in WPR?
- Over the last ten years it is up 11.8%. The long-run trend across the full record is rising.
- Where does this WPR data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hypertension: diagnosis coverage among adults aged 30-79 with hypertension, age-standardized (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).